TV-46139
Total Payments
$60,153
Transactions
3
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $60,153 | 3 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $60,153 | 3 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| TV46139-PK-10089 | Teva Pharmaceuticals USA, Inc. | $57,132 | 0 |
| TV46139-PK-10058 | Teva Pharmaceuticals USA, Inc. | $3,021 | 0 |
Top Doctors Receiving Payments for TV-46139
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Austin, TX | $60,153 | 3 |
Ad
Manufacturing Companies
- Teva Pharmaceuticals USA, Inc. $60,153
Product Information
- Type Drug
- Total Payments $60,153
- Total Doctors 0
- Transactions 3
About TV-46139
TV-46139 is a drug associated with $60,153 in payments to 0 healthcare providers, recorded across 3 transactions in the CMS Open Payments database. The primary manufacturer is Teva Pharmaceuticals USA, Inc..
Payment data is available from 2017 to 2017. In 2017, $60,153 was paid across 3 transactions to 0 doctors.
The most common payment nature for TV-46139 is "Unspecified" ($60,153, 100.0% of total).
TV-46139 is associated with 2 research studies, including "TV46139-PK-10089" ($57,132).